Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children

European Journal of Endocrinology

Volumn 160, Issue 1, 2009, Pages 45-52

  Pacifico, Lucia ^a   Cantisani, Vito ^a   Anania, Caterina ^a   Bonaiuto, Elisabetta ^a   Martino, Francesco ^a   Pascone, Roberto ^a   Chiesa, Claudio ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; CHOLESTEROL; INSULIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; BLOOD PRESSURE; CAROTID ARTERY DISEASE; COHORT ANALYSIS; ECHOGRAPHY; INTIMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; STATISTICAL MODEL;

ALANINE TRANSAMINASE; BLOOD GLUCOSE; BLOOD PRESSURE; CAROTID ARTERY DISEASES; CHILD; CHOLESTEROL; COHORT STUDIES; CREATININE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN; LINEAR MODELS; MALE; METABOLIC SYNDROME X; OBESITY; TRIGLYCERIDES; TUNICA INTIMA; URIC ACID;

EID: 58249094150     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0618     Document Type: Article

References (45)

1. Fang J & Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Follow-up Study, 1971-1992. National Health and Nutrition Examination Survey. Journal of the American Medical Association 2000 283 2404-2410.
2. Bos MJ, Koudstaall PJ, Hofman A, Witteman JC & Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam Study. Stroke 2006 37 1503-1507.
3. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H & the VHM & PP Study Group. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clinical Chemistry 2008 54 273-284.
4. Lippi G, Montagnana M, Franchini M, Favaloro EJ & Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clinica Chimica Acta 2008 392 1-7.
5. Nagahama K, Isei K, Inoue T, Touna T, Ikemiya Y & Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertension Research 2004 27 227-233.
6. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC & Muggeo M. Bruneck study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003 26 1251-1257.
7. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J & Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003 41 1183-1190.
8. Kanellis J & Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Seminars in Nephrology 2005 25 39-42.
9. Ishizaka N, Ishizaka Y, Toda E-I, Nagai R & Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1038-1044.
10. Ishizaka N, Ishizaka Y, Toda E-I, Hashimoto H, Nagai R & Yamakado M. Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 2007 192 131-137.
11. Kawamoto R, Tomita H, Oka Y & Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Internal Medicine 2006 45 605-614.
12. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG & Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Annals of Epidemiology 1996 6 331-340.
13. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE & Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. New England Journal of Medicine 1998 338 1650-1656.
14. Ford ES, Li C, Cook S & Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007 115 2526-2532.
15. Invitti C, Guzzaloni G, Gilardini L, Morabito F & Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 2003 26 118-124.
16. Denzer C, Muche R, Mayer H, Heinze E, Debatin K-M & Wabitsch M. Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. Journal of Pediatric Endocrinology and Metabolism 2003 16 1225-1232.
17. Schiel R, Beltschikow W, Radon S, Kramer G, Perenthaler T & Stein G. Increased carotid intima-media thickness and associations with cardiovascular risk factors in obese and overweight children and adolescents. European Journal of Medical Research 2007 12 503-508.
18. de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC & Kastelein JJ. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004 109 (Suppl 1) III33-III38.
19. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, Akerblom HK & Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the cardiovascular risk in young Finns study. Journal of the American Medical Association 2003 290 2277-2283.
20. Cacciari E, Milani S, Balsamo A, Dammacco F, De Luca F, Chiarelli F, Pasquino AM, Tonini G & Vanelli M. Italian cross-sectional growth charts for eight, weight and BMI (6-20 y). European Journal of Clinical Nutrition 2002 56 171-180.
21. Invitti C, Maffeis C, Gilardini L, Pontiggia B, Mazzilli G, Girola A, Sartorio A, Morabito F & Viberti GC. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. International Journal of Obesity 2006 30 627-633.
22. Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, Anania C, Ferrara E, Dvisic G & Chiesa C. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatric Research 2008 63 423-427.
23. Cole TJ, Bellizzi MC, Flegal KM & Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000 320 1240-1243.
24. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497.
25. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553.
26. Boney CM, Verma A, Tucker R & Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005 115 e290-e296.
27. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on blood cholesterol levels in children and adolescents. Pediatrics 1992 89 525-584.
28. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004 114 555-576.
29. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997 20 1183-1197.
30. Allard P, Delvin EE, Paradis G, Hanley JA, O'Loughlin J, Lavallée C, Levy E & Lambert M. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clinical Chemistry 2003 49 644-649.
31. Pediatric Reference Intervals, edn 6, chapter chemistry tests, pp. 3-215. Eds Soldin SJ, Brugnara C & Wong EC, Washington, DC; American Association for Clinical Chemistry (AACC), 2007.
32. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM & Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. American Journal of Physiology. Renal Physiology 2006 290 F625-F631.
33. Molnar D, Decsi T & Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. International Journal of Obesity 2004 28 1197-1202.
34. Feig DI & Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003 42 247-252.
35. Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang D-H, Finch J & Johnson RJ. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney International 2004 66 281-287.
36. Feig DI. Uric acid and hypertension in adolescents. Seminars in Nephrology 2005 25 32-38.
37. Rathmann W, Funkhouser E, Dyer AR & Roseman JM. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Annals of Epidemiology 1998 8 250-261.
38. Facchini F, Chen YD, Hollenbeck CB & Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. Journal of the American Medical Association 1991 266 3008-3011.
39. Tsunoda S, Kamide K, Minami J & Kawano Y. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. American Journal of Hypertension 2002 15 697-701.
40. Clausen JO, Borch-Johnsen K, Ibsen H & Pedersen O. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. European Journal of Endocrinology 1998 138 63-69.
41. Rao GN, Corson MA & Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. Journal of Biological Chemistry 1991 266 8604-8608.
42. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L & Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003 41 1287-1293.
43. Maclachlan MJ & Rodnan GP. Effect of food, fast and alcohol on serum uric acid and acute attacks of gouts. American Journal of Medicine 1967 42 38-57.
44. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA & Salonen JT. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Archives of Internal Medicine 2004 164 1546-1551.
45. Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM & Berenson GS. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. Journal of the American Medical Association 2003 290 2271-2276.